Technical Analysis for RPRX - Royalty Pharma plc

Grade Last Price % Change Price Change
grade B 47.64 -1.49% -0.72
RPRX closed down 1.49 percent on Friday, July 10, 2020, on 24 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Flat
Historical RPRX trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Narrow Range Bar Range Contraction -1.49%
NR7 Range Contraction -1.49%
Inside Day Range Contraction -1.49%
Up 3 Days in a Row Strength -1.49%
Up 4 Days in a Row Strength -1.49%
Up 3 Days in a Row Strength -0.79%
Bullish Engulfing Bullish 1.25%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Royalty Pharma Plc provides drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The firm's portfolio includes royalties, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta, and Vertex's Kalydeco, Symdeko and Trikafta, and four development-stage product candidates. It focuses on acquiring royalty-generating products segment. The firm invests in biopharmaceutical products. The company was founded by Pablo Gerardo Legorreta in 1996 and is headquartered in New York, NY.
Biotechnology Pharmaceutical Drug Development HIV Biopharmaceutical Products Astellas Pharma Abbvie Inc. Biopharmaceutical Industry Drug Development Services Novartis

Is RPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 56.5
52 Week Low 42.0
Average Volume 2,911,646
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 47.63
Average True Range 3.13
ADX 0.0
+DI 27.78
-DI 16.45
Chandelier Exit (Long, 3 ATRs ) 47.10
Chandelier Exit (Short, 3 ATRs ) 51.40
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -0.56
MACD Signal Line -0.44
MACD Histogram -0.122
Fundamentals Value
Market Cap 1.79 Billion
Num Shares 37.6 Million
EPS -0.62
Price-to-Earnings (P/E) Ratio -76.71
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 49.37
Resistance 3 (R3) 49.50 49.06 49.08
Resistance 2 (R2) 49.06 48.62 48.99 48.98
Resistance 1 (R1) 48.35 48.35 48.13 48.22 48.89
Pivot Point 47.91 47.91 47.80 47.84 47.91
Support 1 (S1) 47.20 47.47 46.98 47.07 46.39
Support 2 (S2) 46.76 47.20 46.69 46.30
Support 3 (S3) 46.05 46.76 46.20
Support 4 (S4) 45.92